APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Pulmonary Valve System

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artificial Pulmonary Valve System Industry Growth and Trends Forecast to 2032

26 December 202594 pages

Choose your research edition.

Industry ResearchArtificial Pulmonary Valve System Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Pulmonary Valve System Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artificial Pulmonary Valve System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Pulmonary Valve System Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Pulmonary Valve System Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Artificial Pulmonary Valve System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artificial Pulmonary Valve System include Edwards Lifesciences, Epicor Medical, Terumo, Valtech Cardio, Boston Scientific, Venus Medtech Medical Device, Medtronic and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artificial Pulmonary Valve System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artificial Pulmonary Valve System market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Pulmonary Valve System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Pulmonary Valve System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Artificial Pulmonary Valve System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artificial Pulmonary Valve System Market by Company

Edwards Lifesciences

Epicor Medical

Terumo

Valtech Cardio

Boston Scientific

Venus Medtech Medical Device

Medtronic

Abbott

Artificial Pulmonary Valve System Segment by Type

PLA

PCL

Others

Artificial Pulmonary Valve System Segment by Application

Pulmonary Valve Regurgitation

Pulmonary Valve Stenosis

Pulmonary Hypertension

Others

Artificial Pulmonary Valve System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pulmonary Valve System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Pulmonary Valve System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pulmonary Valve System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Pulmonary Valve System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PLA Table 2. Major Company of PCL Table 3. Major Company of Others Table 4. Global Artificial Pulmonary Valve System Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 6. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Type (2021-2026) Table 7. Global Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 8. Global Artificial Pulmonary Valve System Sales Market Share in Value by Type (2021-2026) Table 9. Global Artificial Pulmonary Valve System Price by Type (2021-2026) & (US$/Unit) Table 10. Global Artificial Pulmonary Valve System Sales by Type (2027-2032) & (K Units) Table 11. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Type (2027-2032) Table 12. Global Artificial Pulmonary Valve System Sales by Type (2027-2032) & (US$ Million) Table 13. Global Artificial Pulmonary Valve System Sales Market Share in Value by Type (2027-2032) Table 14. Global Artificial Pulmonary Valve System Price by Type (2027-2032) & (US$/Unit) Table 15. North America Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 16. North America Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 18. Europe Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 22. Latin America Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Artificial Pulmonary Valve System Sales by Type (2021-2026) & (US$ Million) Table 25. Artificial Pulmonary Valve System Industry Trends Table 26. Artificial Pulmonary Valve System Industry Drivers Table 27. Artificial Pulmonary Valve System Industry Opportunities and Challenges Table 28. Artificial Pulmonary Valve System Industry Restraints Table 29. Global Artificial Pulmonary Valve System Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Artificial Pulmonary Valve System Revenue Market Share by Company (2021-2026) Table 31. Global Artificial Pulmonary Valve System Sales by Company (2021-2026) & (K Units) Table 32. Global Artificial Pulmonary Valve System Sales Share by Company (2021-2026) Table 33. Global Artificial Pulmonary Valve System Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Artificial Pulmonary Valve System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Artificial Pulmonary Valve System Major Company Production Sites and Headquarters Table 36. Global Artificial Pulmonary Valve System Company, Product Type & Application Table 37. Global Artificial Pulmonary Valve System Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Artificial Pulmonary Valve System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Artificial Pulmonary Valve System Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Artificial Pulmonary Valve System Sales by Region (2021-2026) & (K Units) Table 42. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Region (2021-2026) Table 43. Global Artificial Pulmonary Valve System Sales by Region (2021-2026) & (US$ Million) Table 44. Global Artificial Pulmonary Valve System Sales Market Share in Value by Region (2021-2026) Table 45. Global Artificial Pulmonary Valve System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Artificial Pulmonary Valve System Sales by Region (2027-2032) & (K Units) Table 47. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Region (2027-2032) Table 48. Global Artificial Pulmonary Valve System Sales by Region (2027-2032) & (US$ Million) Table 49. Global Artificial Pulmonary Valve System Sales Market Share in Value by Region (2027-2032) Table 50. Global Artificial Pulmonary Valve System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Artificial Pulmonary Valve System Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 53. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Application (2021-2026) Table 54. Global Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 55. Global Artificial Pulmonary Valve System Sales Market Share in Value by Application (2021-2026) Table 56. Global Artificial Pulmonary Valve System Price by Application (2021-2026) & (US$/Unit) Table 57. Global Artificial Pulmonary Valve System Sales by Application (2027-2032) & (K Units) Table 58. Global Artificial Pulmonary Valve System Sales Market Share in Volume by Application (2027-2032) Table 59. Global Artificial Pulmonary Valve System Sales by Application (2027-2032) & (US$ Million) Table 60. Global Artificial Pulmonary Valve System Sales Market Share in Value by Application (2027-2032) Table 61. Global Artificial Pulmonary Valve System Price by Application (2027-2032) & (US$/Unit) Table 62. North America Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 63. North America Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 65. Europe Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 69. Latin America Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Artificial Pulmonary Valve System Sales by Application (2021-2026) & (US$ Million) Table 72. Edwards Lifesciences Company Information Table 73. Edwards Lifesciences Business Overview Table 74. Edwards Lifesciences Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio Table 76. Edwards Lifesciences Recent Development Table 77. Epicor Medical Company Information Table 78. Epicor Medical Business Overview Table 79. Epicor Medical Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Epicor Medical Artificial Pulmonary Valve System Product Portfolio Table 81. Epicor Medical Recent Development Table 82. Terumo Company Information Table 83. Terumo Business Overview Table 84. Terumo Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Terumo Artificial Pulmonary Valve System Product Portfolio Table 86. Terumo Recent Development Table 87. Valtech Cardio Company Information Table 88. Valtech Cardio Business Overview Table 89. Valtech Cardio Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Valtech Cardio Artificial Pulmonary Valve System Product Portfolio Table 91. Valtech Cardio Recent Development Table 92. Boston Scientific Company Information Table 93. Boston Scientific Business Overview Table 94. Boston Scientific Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Boston Scientific Artificial Pulmonary Valve System Product Portfolio Table 96. Boston Scientific Recent Development Table 97. Venus Medtech Medical Device Company Information Table 98. Venus Medtech Medical Device Business Overview Table 99. Venus Medtech Medical Device Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio Table 101. Venus Medtech Medical Device Recent Development Table 102. Medtronic Company Information Table 103. Medtronic Business Overview Table 104. Medtronic Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Medtronic Artificial Pulmonary Valve System Product Portfolio Table 106. Medtronic Recent Development Table 107. Abbott Company Information Table 108. Abbott Business Overview Table 109. Abbott Artificial Pulmonary Valve System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Abbott Artificial Pulmonary Valve System Product Portfolio Table 111. Abbott Recent Development Table 112. North America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 114. North America Artificial Pulmonary Valve System Sales Market Share by Country (2021-2026) Table 115. North America Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Artificial Pulmonary Valve System Sales Market Share Forecast by Country (2027-2032) Table 117. North America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Artificial Pulmonary Valve System Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Artificial Pulmonary Valve System Market Share by Country (2021-2026) Table 120. North America Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Artificial Pulmonary Valve System Market Share Forecast by Country (2027-2032) Table 122. Europe Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 124. Europe Artificial Pulmonary Valve System Sales Market Share by Country (2021-2026) Table 125. Europe Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Artificial Pulmonary Valve System Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Artificial Pulmonary Valve System Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Artificial Pulmonary Valve System Market Share by Country (2021-2026) Table 130. Europe Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Artificial Pulmonary Valve System Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Artificial Pulmonary Valve System Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Artificial Pulmonary Valve System Market Share by Country (2021-2026) Table 140. Asia-Pacific Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Artificial Pulmonary Valve System Market Share Forecast by Country (2027-2032) Table 142. Latin America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 144. Latin America Artificial Pulmonary Valve System Sales Market Share by Country (2021-2026) Table 145. Latin America Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Artificial Pulmonary Valve System Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Artificial Pulmonary Valve System Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Artificial Pulmonary Valve System Market Share by Country (2021-2026) Table 150. Latin America Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Artificial Pulmonary Valve System Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Artificial Pulmonary Valve System Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Artificial Pulmonary Valve System Market Share by Country (2021-2026) Table 160. Middle East and Africa Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Artificial Pulmonary Valve System Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Artificial Pulmonary Valve System Distributors List Table 165. Artificial Pulmonary Valve System Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Artificial Pulmonary Valve System Image Figure 2. Global Artificial Pulmonary Valve System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Pulmonary Valve System Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Pulmonary Valve System Sales (2021-2032) & (K Units) Figure 5. PLA Image Figure 6. Global PLA Sales YoY Growth (2021-2032) & (K Units) Figure 7. PCL Image Figure 8. Global PCL Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Artificial Pulmonary Valve System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Artificial Pulmonary Valve System Market Share by Type 2025 VS 2032 Figure 13. North America Artificial Pulmonary Valve System Sales Market Share in Volume by Type in 2025 Figure 14. North America Artificial Pulmonary Valve System Sales Market Share in Value by Type in 2025 Figure 15. Europe Artificial Pulmonary Valve System Sales Market Share in Volume by Type in 2025 Figure 16. Europe Artificial Pulmonary Valve System Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share in Value by Type in 2025 Figure 19. Latin America Artificial Pulmonary Valve System Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Artificial Pulmonary Valve System Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pulmonary Valve Regurgitation Image Figure 26. Global Pulmonary Valve Regurgitation Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pulmonary Valve Stenosis Image Figure 28. Global Pulmonary Valve Stenosis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Pulmonary Hypertension Image Figure 30. Global Pulmonary Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Artificial Pulmonary Valve System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Artificial Pulmonary Valve System Market Share by Application 2025 VS 2032 Figure 35. North America Artificial Pulmonary Valve System Sales Market Share in Volume by Application in 2025 Figure 36. North America Artificial Pulmonary Valve System Sales Market Share in Value by Application in 2025 Figure 37. Europe Artificial Pulmonary Valve System Sales Market Share in Volume by Application in 2025 Figure 38. Europe Artificial Pulmonary Valve System Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Artificial Pulmonary Valve System Sales Market Share in Value by Application in 2025 Figure 41. Latin America Artificial Pulmonary Valve System Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Artificial Pulmonary Valve System Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Artificial Pulmonary Valve System Sales Market Share in Value by Application in 2025 Figure 45. North America Artificial Pulmonary Valve System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Artificial Pulmonary Valve System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Artificial Pulmonary Valve System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Artificial Pulmonary Valve System Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Artificial Pulmonary Valve System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Artificial Pulmonary Valve System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Artificial Pulmonary Valve System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Artificial Pulmonary Valve System Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Artificial Pulmonary Valve System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Artificial Pulmonary Valve System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Artificial Pulmonary Valve System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Artificial Pulmonary Valve System Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Artificial Pulmonary Valve System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Artificial Pulmonary Valve System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Artificial Pulmonary Valve System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Artificial Pulmonary Valve System Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Artificial Pulmonary Valve System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Artificial Pulmonary Valve System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Artificial Pulmonary Valve System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Artificial Pulmonary Valve System Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Artificial Pulmonary Valve System Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Artificial Pulmonary Valve System Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • PLA
  • PCL
  • Others
Applications
  • Pulmonary Valve Regurgitation
  • Pulmonary Valve Stenosis
  • Pulmonary Hypertension
  • Others
Companies covered
  • Edwards Lifesciences
  • Epicor Medical
  • Terumo
  • Valtech Cardio
  • Boston Scientific
  • Venus Medtech Medical Device
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Pulmonary Valve System Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Artificial Pulmonary Valve System Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Artificial Pulmonary Valve System Market by Type
  6. 1.3.1 PLA
  7. 1.3.2 PCL
  8. 1.3.3 Others
  9. 1.4 Global Artificial Pulmonary Valve System Market Size by Type
  10. 1.4.1 Global Artificial Pulmonary Valve System Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Artificial Pulmonary Valve System Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Artificial Pulmonary Valve System Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Artificial Pulmonary Valve System Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Artificial Pulmonary Valve System Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Artificial Pulmonary Valve System Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Artificial Pulmonary Valve System Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Artificial Pulmonary Valve System Industry Trends
  2. 2.2 Artificial Pulmonary Valve System Industry Drivers
  3. 2.3 Artificial Pulmonary Valve System Industry Opportunities and Challenges
  4. 2.4 Artificial Pulmonary Valve System Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Artificial Pulmonary Valve System Revenue (2021-2026)
  2. 3.2 Global Top Players by Artificial Pulmonary Valve System Sales (2021-2026)
  3. 3.3 Global Top Players by Artificial Pulmonary Valve System Price (2021-2026)
  4. 3.4 Global Artificial Pulmonary Valve System Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artificial Pulmonary Valve System Major Company Production Sites & Headquarters
  6. 3.6 Global Artificial Pulmonary Valve System Company, Product Type & Application
  7. 3.7 Global Artificial Pulmonary Valve System Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artificial Pulmonary Valve System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artificial Pulmonary Valve System Tier 1, Tier 2, and Tier 3
4 Artificial Pulmonary Valve System Regional Status and Outlook
  1. 4.1 Global Artificial Pulmonary Valve System Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Artificial Pulmonary Valve System Historic Market Size by Region
  3. 4.2.1 Global Artificial Pulmonary Valve System Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Artificial Pulmonary Valve System Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Artificial Pulmonary Valve System Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Region
  7. 4.3.1 Global Artificial Pulmonary Valve System Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Artificial Pulmonary Valve System Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Artificial Pulmonary Valve System Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artificial Pulmonary Valve System by Application
  1. 5.1 Artificial Pulmonary Valve System Market by Application
  2. 5.1.1 Pulmonary Valve Regurgitation
  3. 5.1.2 Pulmonary Valve Stenosis
  4. 5.1.3 Pulmonary Hypertension
  5. 5.1.4 Others
  6. 5.2 Global Artificial Pulmonary Valve System Market Size by Application
  7. 5.2.1 Global Artificial Pulmonary Valve System Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Artificial Pulmonary Valve System Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Artificial Pulmonary Valve System Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Artificial Pulmonary Valve System Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Artificial Pulmonary Valve System Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Artificial Pulmonary Valve System Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Artificial Pulmonary Valve System Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Artificial Pulmonary Valve System Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Edwards Lifesciences
  2. 6.1.1 Edwards Lifesciences Company Information
  3. 6.1.2 Edwards Lifesciences Business Overview
  4. 6.1.3 Edwards Lifesciences Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio
  6. 6.1.5 Edwards Lifesciences Recent Developments
  7. 6.2 Epicor Medical
  8. 6.2.1 Epicor Medical Company Information
  9. 6.2.2 Epicor Medical Business Overview
  10. 6.2.3 Epicor Medical Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Epicor Medical Artificial Pulmonary Valve System Product Portfolio
  12. 6.2.5 Epicor Medical Recent Developments
  13. 6.3 Terumo
  14. 6.3.1 Terumo Company Information
  15. 6.3.2 Terumo Business Overview
  16. 6.3.3 Terumo Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Terumo Artificial Pulmonary Valve System Product Portfolio
  18. 6.3.5 Terumo Recent Developments
  19. 6.4 Valtech Cardio
  20. 6.4.1 Valtech Cardio Company Information
  21. 6.4.2 Valtech Cardio Business Overview
  22. 6.4.3 Valtech Cardio Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Valtech Cardio Artificial Pulmonary Valve System Product Portfolio
  24. 6.4.5 Valtech Cardio Recent Developments
  25. 6.5 Boston Scientific
  26. 6.5.1 Boston Scientific Company Information
  27. 6.5.2 Boston Scientific Business Overview
  28. 6.5.3 Boston Scientific Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boston Scientific Artificial Pulmonary Valve System Product Portfolio
  30. 6.5.5 Boston Scientific Recent Developments
  31. 6.6 Venus Medtech Medical Device
  32. 6.6.1 Venus Medtech Medical Device Company Information
  33. 6.6.2 Venus Medtech Medical Device Business Overview
  34. 6.6.3 Venus Medtech Medical Device Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio
  36. 6.6.5 Venus Medtech Medical Device Recent Developments
  37. 6.7 Medtronic
  38. 6.7.1 Medtronic Company Information
  39. 6.7.2 Medtronic Business Overview
  40. 6.7.3 Medtronic Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Medtronic Artificial Pulmonary Valve System Product Portfolio
  42. 6.7.5 Medtronic Recent Developments
  43. 6.8 Abbott
  44. 6.8.1 Abbott Company Information
  45. 6.8.2 Abbott Business Overview
  46. 6.8.3 Abbott Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abbott Artificial Pulmonary Valve System Product Portfolio
  48. 6.8.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Artificial Pulmonary Valve System Sales by Country
  2. 7.1.1 North America Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Artificial Pulmonary Valve System Sales by Country (2021-2026)
  4. 7.1.3 North America Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032)
  5. 7.2 North America Artificial Pulmonary Valve System Market Size by Country
  6. 7.2.1 North America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Artificial Pulmonary Valve System Market Size by Country (2021-2026)
  8. 7.2.3 North America Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Artificial Pulmonary Valve System Sales by Country
  2. 8.1.1 Europe Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Artificial Pulmonary Valve System Sales by Country (2021-2026)
  4. 8.1.3 Europe Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Artificial Pulmonary Valve System Market Size by Country
  6. 8.2.1 Europe Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Artificial Pulmonary Valve System Market Size by Country (2021-2026)
  8. 8.2.3 Europe Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Artificial Pulmonary Valve System Sales by Country
  2. 9.1.1 Asia-Pacific Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Artificial Pulmonary Valve System Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Artificial Pulmonary Valve System Market Size by Country
  6. 9.2.1 Asia-Pacific Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Artificial Pulmonary Valve System Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Artificial Pulmonary Valve System Sales by Country
  2. 10.1.1 South America Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Artificial Pulmonary Valve System Sales by Country (2021-2026)
  4. 10.1.3 South America Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032)
  5. 10.2 South America Artificial Pulmonary Valve System Market Size by Country
  6. 10.2.1 South America Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Artificial Pulmonary Valve System Market Size by Country (2021-2026)
  8. 10.2.3 South America Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Artificial Pulmonary Valve System Sales by Country
  2. 11.1.1 Middle East and Africa Artificial Pulmonary Valve System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Artificial Pulmonary Valve System Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Artificial Pulmonary Valve System Market Size by Country
  6. 11.2.1 Middle East and Africa Artificial Pulmonary Valve System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Artificial Pulmonary Valve System Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Artificial Pulmonary Valve System Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Artificial Pulmonary Valve System Value Chain Analysis
  2. 12.1.1 Artificial Pulmonary Valve System Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Artificial Pulmonary Valve System Production Mode & Process
  7. 12.2 Artificial Pulmonary Valve System Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Artificial Pulmonary Valve System Distributors
  10. 12.2.3 Artificial Pulmonary Valve System Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst